WebJan 15, 2024 · Thermo Fisher Scientific Inc., (NYSE: TMO), the world leader in serving science, and Groupe Novasep SAS (Novasep), a leading supplier of services and technologies for the life sciences industry, today announced that Thermo Fisher has completed the acquisition of Henogen S.A., Novasep's viral vector manufacturing … WebThermo Fisher Scientific Inc. (NYSE: TMO) is the world leader in serving science, with annual revenue of approximately $40 billion. Our Mission is to enable our customers to make the world healthier, cleaner, and safer.

Thermo Fisher strikes again in viral vectors - Chemical

WebJan 15, 2024 · Thermo Fisher Scientific has acquired the viral-vector manufacturing business of the French pharmaceutical services firm Novasep for approximately $875 … WebJan 15, 2024 · Thermo Fisher closes Henogen acquisition By The Science Advisory Board staff writers. January 15, 2024-- Thermo Fisher Scientific has closed its acquisition of Groupe Novasep's Henogen, a viral vector manufacturing business in Belgium, for approximately 725 million euros ($876 million U.S.) in cash. destiny 2 borrowed time light gg

Thermo Fisher Completes $875-Million Acquisition of Novasep

WebJan 19, 2024 · French-based CDMO Novasep has announced two sales. Henagen, its Belgium-based viral vectors operation, has been sold to Thermo Fisher Scientific for about €725 million, while, in a much smaller deal, it also intends to sell its chromatography equipment division to Sartorius Stedim Biotech. WebJan 15, 2024 · Medical device maker Thermo Fisher Scientific Inc said on Friday it has completed acquisition of Henogen SA, a Belgium-based viral vector manufacturing … WebJan 15, 2024 · Buoyed by revenues from COVID-19 testing over the past year, Thermo Fisher announced that it has now acquired Henogen, Novasep's viral vector manufacturing division, for about €725 million or ... chucky english chicago